Gabriel, L.

argatroban group patient infusion thrombin angioplasty level study infusion rate coagulation t h e t h r t r e 4 hour infusion value p t t plasma dosage balloon angioplasty table effect heparin angina result model second argatroban plasma level b l e prothrombin fragments 1 dosage group prothrombin thrombosis balloon percutaneous transluminal inhibitor fuster v 24 hours coagulation parameters thromboplastin time sheath removal chesebro jh 4 hours thrombin inhibitor treatment 300 seconds group b administration r e value r e l circulation e n t angiogram removal blood infarction 68 hours study medication netherland thrombin inhibition argatroban infusion platelet therapy badimon l coagulation system analysis catheter sheath relationship system badimon range safety hirudin inhibition anticoagulant increase f 1.2 levels transluminal puncture parameter